Release test results
99.721%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.04 mg
Related impurities (total)0.279%
Endotoxin<1.0 EU/mg
HPLC retention time8.11 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundEpitalon
Presentation10 MG
Lot numberRGX-26-RGNX-732
COA numberNS-2026-05211
Test date26 Mar 2026
Release date29 Mar 2026
Independent labNordicstar Labs
StatusSuperseded
Epitalon — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-RGNX-1068 | 10 MG | Jul 5, 2026 | 99.654% | Current |
| RGX-26-RGNX-1069 | 50 MG | Jul 4, 2026 | 99.576% | Current |
| RGX-26-RGNX-731 | 50 MG | Mar 27, 2026 | 99.645% | Superseded |
| RGX-26-RGNX-732 this lot | 10 MG | Mar 26, 2026 | 99.721% | Superseded |
| RGX-25-RGNX-632 | 10 MG | Dec 27, 2025 | 99.683% | Superseded |
| RGX-25-RGNX-631 | 50 MG | Dec 20, 2025 | 99.690% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →